Presentation
Design for FDA: A Predictive Model for the FDA’s Decision Time for Medical Devices
SME 2013 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference
(2013)
Abstract
The concept of Design for FDA (DfFDA) has a strong basis on the Food and Drug Administration’s (FDA) regulation for medical devices in the Unites States. In fact; an analysis of the factors that impact the time it takes the FDA’s to provide market approval for medical devices, the product design process model, and Design for X (DfX) methods with overlapping FDA objectives lead to the development of DfFDA as a means to increase awareness about regulatory compliance and promote designers to consider the regulations throughout the development process of medical devices. For doing so, the main objective of DfFDA is to provide regulation-focused guidelines to producers of medical devices. An important part of these guidelines and this paper’s major contribution is the development of a prediction model for the FDA’s decision time. Overall, we want this model to become a tool that allows medical device companies to come up with an accurate estimate of a product’s time-to-market after accounting for the FDA’s decision time. In this work, we provide a comparison and discussion on the adequacy of linear regression models and other non-linear models such as parallel and serial tree-based ensembles for prediction the FDA’s decision time.
Disciplines
Publication Date
August, 2013
Location
Portland, OR
DOI
10.1115/DETC2013-13606
Comments
Copyright © 2013 by ASME
Citation Information
Lourdes A. Medina, Saylisse Davila, Gül E. Okudan-Kremer and Richard A. Wysk. "Design for FDA: A Predictive Model for the FDA’s Decision Time for Medical Devices" SME 2013 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference (2013) Available at: http://works.bepress.com/gul-kremer/41/